Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019

Health care resource utilization and disease modifying treatment use in multiple sclerosis patients by age and insurance type

(2021) Miriam Cisternas et al.   CURRENT MEDICAL RESEARCH AND OPINION

Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy

(2020) James Bowen et al.   ADVANCES IN THERAPY

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

(2019) Ai-Lan Nguyen et al.   Multiple Sclerosis and Related Disorders

Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis

(2019) Sarah C. MacDonald et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Caring for Women with Multiple Sclerosis Across the Lifespan

(2018) Kelsey Rankin et al.   Current Neurology and Neuroscience Reports

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis

(2018) Alexander Rae-Grant et al.   NEUROLOGY

Pregnancy rates and outcomes in women with and without MS in the United States

(2018) Maria K. Houtchens et al.   NEUROLOGY

Adherence to Disease-Modifying Therapies for Multiple Sclerosis

(2016) Lucas Higuera et al.   Journal of Managed Care & Specialty Pharmacy

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States

(2016) Carl V. Asche et al.   JOURNAL OF MANAGED CARE PHARMACY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis

(2011) T Chitnis et al.   Multiple Sclerosis Journal

Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims

(2010) Benjamin J. Chastek et al.   JOURNAL OF MEDICAL ECONOMICS